Study of Antithrombotic Treatment After Intracerebral Hemorrhage-Antiplatelets: A Randomized Trial - PubMed
6 hours ago
- #Intracerebral Hemorrhage
- #Randomized Trial
- #Antiplatelet Therapy
- The STATICH trial assessed the safety and efficacy of long-term antithrombotic treatment post-intracerebral hemorrhage (ICH).
- It was a randomized, open-label study comparing starting versus avoiding antiplatelet treatment in ICH survivors with indications for antithrombotics.
- Recurrent symptomatic ICH was the primary safety outcome; the trial stopped early due to slow recruitment, with 69 participants enrolled.
- Recurrent ICH occurred more frequently in the start group (15%) than the avoid group (3%), while ischemic events were less common in the start group (9% vs. 20%).
- Findings will contribute to a planned individual patient-data meta-analysis to address treatment dilemmas in this high-risk population.